Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved-Reference-Cited by-同舟云学术

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

Published:2023-10-25 Issue: Volume: Page:
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Ragone María Inés,Bayley Matías,López Sofía,Díaz Romina G.,Consolini Alicia E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-023-02791-0.pdf

Reference55 articles.

1. Al Habeeb W, Mrabeti S, Abdelsalam AAI (2022) Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc Drugs Ther 36(5):959–971. https://doi.org/10.1007/s10557-021-07205-y

2. Ambrosio G, Flather MD, Böhm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJS (2011) β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3):209–214. https://doi.org/10.1136/hrt.2010.207365

3. Audigane L, Persello A, Piriou N, Ferron M, Trochu J-N, Lauzier B, Gauthier C, Rozec B (2021) Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3-adrenoceptor remodelling. Clin Exp Pharmacol Physiol 48(7):1007–1015. https://doi.org/10.1111/1440-1681.13447

4. Bermudez-Gonzalez JL, Sanchez-Quintero D, Proaño-Bernal L, Santana-Apreza R, Jimenez-Chavarria MA, Luna-Alvarez-Amezquita JA, Straface JI, Perez-Partida AM, Berarducci J, Armenta-Moreno JI, Garza-Cruz KJ, Espinola-Zavaleta N, Alexanderson-Rosas E (2022) Role of the antioxidant activity of melatonin in myocardial ischemia-reperfusion injury. Antioxidants 11(4):627–632. https://doi.org/10.3390/antiox11040627

5. Bolli R (2001) Cardioprotective Function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897–1918. https://doi.org/10.1006/jmcc.2001.1462